Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Sravanti Rangaraju
Assistant Professor
Close
E-mail
srangaraju@uabmc.edu
srangaraju@uabmc.edu
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Sravanti Rangaraju
Assistant Professor
Positions
Assistant Professor (P)
,
Medicine - Hematology & Oncology
,
Department of Medicine
2020 -
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2019
Cooperativity between Flt3/Syk and Proteasome Inhibitors in Flt3mutant/Wildtype AML, By Acting on the Oxphos and Wnt Endpoints of Syk and p62SQSTM1 Pathways Prohibits Protective Autophagy; While Downregulation of NRF2, NQO1, Jun, and b-Catenin Bypasses Interfering RAS or WT1 Co-Mutations
.
Blood
. 134:5051-5051.
2019
2018
Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease
.
Blood
. 132:2506-2519.
2018
2018
Identification of Beta-Catenin As a Novel Ubiquitin-Regulated Target of Combined Flβ3/Syk- and Proteasome Inhibitors for Interruption of LSC Signaling in Poor-Risk AML
.
Blood
. 132:3949-3949.
2018
2015
Lateral Gene Transfer Contributing to Leukemogenesis
.
Blood
. 126:1235-1235.
2015
2014
Administration of a Tryptophan Metabolite, Indole-3-Carboxaldehyde, Reduces Graft Versus Host Disease Morbidity and Mortality and Enhances Gastrointestinal Barrier Function in a Murine Model of Allogeneic Bone Marrow Transplantation
.
Blood
. 124:2420-2420.
2014
2014
Similar Survival for Patients Undergoing Reduced-Intensity Total Body Irradiation (TBI) Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia
2014
2013
Blocking VIP Signaling Abrogates Upregulation Of PD1 and Increases Proliferation Of Allo-Reactive T-Cells In a Mixed Lymphocyte Reaction
.
Blood
. 122:1041-1041.
2013
2013
Pharmacological Inhibition Of Semi-Direct Alloantigen Presentation and The Generation Of Cross-Dressed Antigen Presenting Cells: A Novel approach To Limit Graft Versus Host Disease Following Allogeneic Hematopoetic Stem Cell Transplantation
.
Blood
. 122:294-294.
2013
2013
Similar Survival for Patients Undergoing Reduced-Intensity TBI Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia
2013
Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
Research
Investigator On
Private Grant
awarded by
AMGEN, INC.
2020 - 2024
Private Grant
awarded by
INCYTE CORPORATION
2020 - 2024
Private Grant
awarded by
MARKER THERAPEUTICS INC
2021 - 2024
Background
Education And Training
Bachelor of Medicine & Surgery (MBBS) in Family Medicine Residency Program,
Sikkim Manipal University of Health/Medical and Technology Science
2011
University of Minnesota, Residency
2014
Emory University School of Medicine, Postdoctoral Fellowship
2014
Contact
Full Name
Sravanti
Rangaraju